ALEC
Price
$2.40
Change
+$0.04 (+1.69%)
Updated
Aug 27 closing price
Capitalization
238.86M
75 days until earnings call
ONCO
Price
$2.94
Change
-$0.15 (-4.85%)
Updated
Aug 27 closing price
Capitalization
4.54M
77 days until earnings call
Interact to see
Advertisement

ALEC vs ONCO

Header iconALEC vs ONCO Comparison
Open Charts ALEC vs ONCOBanner chart's image
Alector
Price$2.40
Change+$0.04 (+1.69%)
Volume$683.8K
Capitalization238.86M
Onconetix
Price$2.94
Change-$0.15 (-4.85%)
Volume$45.1K
Capitalization4.54M
ALEC vs ONCO Comparison Chart in %
Loading...
ALEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ONCO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALEC vs. ONCO commentary
Aug 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALEC is a StrongBuy and ONCO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 28, 2025
Stock price -- (ALEC: $2.40 vs. ONCO: $2.94)
Brand notoriety: ALEC and ONCO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALEC: 70% vs. ONCO: 6%
Market capitalization -- ALEC: $238.86M vs. ONCO: $4.54M
ALEC [@Biotechnology] is valued at $238.86M. ONCO’s [@Biotechnology] market capitalization is $4.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $99.27B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALEC’s FA Score shows that 0 FA rating(s) are green whileONCO’s FA Score has 1 green FA rating(s).

  • ALEC’s FA Score: 0 green, 5 red.
  • ONCO’s FA Score: 1 green, 4 red.
According to our system of comparison, ONCO is a better buy in the long-term than ALEC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALEC’s TA Score shows that 5 TA indicator(s) are bullish while ONCO’s TA Score has 6 bullish TA indicator(s).

  • ALEC’s TA Score: 5 bullish, 4 bearish.
  • ONCO’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, ONCO is a better buy in the short-term than ALEC.

Price Growth

ALEC (@Biotechnology) experienced а +9.09% price change this week, while ONCO (@Biotechnology) price change was +7.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.04%. For the same industry, the average monthly price growth was +19.75%, and the average quarterly price growth was +30.54%.

Reported Earning Dates

ALEC is expected to report earnings on Nov 11, 2025.

ONCO is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Biotechnology (+4.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALEC($239M) has a higher market cap than ONCO($4.54M). ALEC YTD gains are higher at: 26.984 vs. ONCO (-94.510). ONCO has higher annual earnings (EBITDA): -43.75M vs. ALEC (-125.18M). ALEC has more cash in the bank: 307M vs. ONCO (284K). ONCO has less debt than ALEC: ONCO (8.75M) vs ALEC (39.5M). ALEC has higher revenues than ONCO: ALEC (81.1M) vs ONCO (1.33M).
ALECONCOALEC / ONCO
Capitalization239M4.54M5,260%
EBITDA-125.18M-43.75M286%
Gain YTD26.984-94.510-29%
P/E RatioN/A0.00-
Revenue81.1M1.33M6,112%
Total Cash307M284K108,099%
Total Debt39.5M8.75M451%
FUNDAMENTALS RATINGS
ALEC: Fundamental Ratings
ALEC
OUTLOOK RATING
1..100
27
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
94
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALECONCO
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 21 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 10 days ago
87%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ALEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ONCO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LAMR127.552.26
+1.80%
Lamar Advertising Company
IDYA25.000.14
+0.56%
IDEAYA Biosciences
TRC17.38-0.02
-0.11%
Tejon Ranch Co
UFI4.45-0.01
-0.22%
UNIFI
OGEN1.10-0.02
-1.79%
Oragenics

ONCO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ONCO has been loosely correlated with PCSA. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ONCO jumps, then PCSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONCO
1D Price
Change %
ONCO100%
-4.85%
PCSA - ONCO
35%
Loosely correlated
-4.79%
APM - ONCO
28%
Poorly correlated
-10.00%
TRDA - ONCO
26%
Poorly correlated
+1.25%
ALEC - ONCO
25%
Poorly correlated
+1.69%
NBTX - ONCO
25%
Poorly correlated
+7.33%
More